Summit Therapeutics
Price & Volume
Stats
See moreOpen | $16.20 |
Previous Close | $15.80 |
Day Range | $15.90-$16.43 |
52W Range | $12.07-$29.23 |
Market Cap | $11.8B |
Shares Short | 40M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $705,000 |
Diluted EPS | -$1.11 |
News
See moreYahoo Finance • 5 days ago
Summit Therapeutics (SMMT) Could Be 46% Undervalued On New Cancer Trials And AI Deal
Yahoo Finance • 10 days ago
Summit Therapeutics reports survival benefit for cancer drug in trial
Yahoo Finance • 12 days ago
Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
Yahoo Finance • 18 days ago
Summit Therapeutics (SMMT) Stock Fair Value Edges Higher After AstraZeneca Deal And Trial Focus
About
CEO | Mr. Robert W. Duggan |
CFO | Mr. Manmeet Singh Soni CPA |
Address | 601 Brickell Key Drive, Miami, FL, United States, 33131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 265 |